Holdings Information
Migraine / David W. Dodick, MD, FRCP, Mayo Clinic, College of Medicine, Scottsdale, AZ, Stephen D. Silberstein, MD, FRCP, Thomas Jefferson University, Philadelphia, PA.
Bibliographic Record Display
-
Title:Migraine / David W. Dodick, MD, FRCP, Mayo Clinic, College of Medicine, Scottsdale, AZ, Stephen D. Silberstein, MD, FRCP, Thomas Jefferson University, Philadelphia, PA.
-
Author/Creator:Dodick, David, author.
-
Other Contributors/Collections:Silberstein, Stephen D., author.
Davidoff, Robert A., 1934- Migraine. Preceded by (work):
-
Published/Created:New York, NY, United States of America : Oxford University Press, [2016]
-
Holdings
Holdings Record Display
-
Location:BMB LIBRARY (VGH) stacksWhere is this?
-
Call Number: WL344 .D646m 2016
-
Number of Items:1
-
Status:Available
-
Location:WOODWARD LIBRARY stacksWhere is this?
-
Call Number: WL344 .D646m 2016
-
Number of Items:1
-
Status:Available
-
Location:BMB LIBRARY (VGH) stacksWhere is this?
-
Library of Congress Subjects:Migraine.
-
Medical Subjects: Migraine Disorders.
-
Edition:Third edition.
-
Description:x, 306 pages : illustrations (chiefly color) ; 26 cm
-
Series:Contemporary neurology series ; 91.
-
Notes:Preceded by: Migraine : manifestations, pathogenesis, and management / Robert A. Davidoff. 2nd ed. 2002.
Includes bibliographical references and index.
-
ISBN:9780199793617 (hardback)
0199793611 (hardback)
9780190205768
0190205768
-
Contents:Machine generated contents note: Introduction
Phases And Clinical Features Of Migraine
Premonitory Phase (Prodrome)
Aura
Headache
Associated Phenomena
Common Non-ICHD Symptoms
Postdrome
Classification Of Migraine
Migraine without Aura
Migraine with Aura
Migraine Aura Without Headache
Chronic Migraine
Complications of Migraine
Migraine Aura-Triggered Seizure
Episodic Syndromes That May Be Associated with Migraine
Migraine Diagnosis Using ID Migraine[™]
Introduction
Genome
Chromosome
Epigenetics
Non-Coding RNA (NCRNA)
Implications For Migraine Research
Migraine Genetics
Familial Hemiplegic Migraine: A Monogenic Migraine Subtype
Genes for Common Migraine Subtypes
Migraine Genome-Wide Association Studies
Other Migraine Genes
Migraine and Genetic Vasculopathies
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts And Leukoencephalopathy
Retinal Vasculopathy With Cerebral Leukodystrophy (RVCL)
Hereditary Systemic Angiopathy
COL4A1-Related Disorder
References
Probable Migraine
Hemiplegic Migraine
Migraine With Brainstem Aura
Retinal Migraine
Visual Snow
Vestibular Migraine
Epilepsy And Migraine
References
Migraine, Cardiovascular, And Cerebrovascular Disease
Pregnancy-Related Hypertension
Coronary Heart Disease
Congenital Heart Defects
Epilepsy
Psychiatric Comorbidity
Pain
Obesity
Allergy
Association Between Restless Legs Syndrome And Migraine
Migraine, Raynaud's Syndrome, And Other Rheumatologic Disorders
References
Introduction
Pathophysiology
Anatomy of Cephalic Pain
Headache
Does Migraine Headache Result from Vasodilation?
Sensitization In Migraine
Peripheral Sensitization
Central Sensitization
Does Sensitization Play a Role in Headache?
Pain Modulation
Neuroimaging
Aura And Headache
What Could Initiate Activation of Trigeminovascular Afferents in the Absence of a Clinical Aura?
Associated Symptoms Of Migraine
Photophobia
Phonophobia
Nausea/Emesis
Conclusion
References
Relaxation Training
Cognitive Behavioral Therapy
Biofeedback
Behavioral Treatment Approaches
Efficacy Of Behavioral Treatments
Limited And No-Contact Behavioral Interventions
Telephone-Administered Treatment
Internet- And Mass Media[
]administered Treatment
Mindfulness-Based Stress Reduction
Exercise
Combining Behavioral And Drug Therapy
Comorbid Mood Disorders
Older Adults
Children And Adolescents
School-Based Behavioral Interventions
Pregnancy
References
Introduction
General Principles
Acute Treatment Strategy
Timing of Administration
Formulation
Use of Adjunctive Medications
Rescue Therapy
Avoid Acute Medication Overuse
Acute Medications
Migraine Specific Medications
Other Migraine-Specific Medications
Non-Specific Medications
Simple Analgesics and NSAIDs
Opioids
Butalbital-Containing Products
Neuroleptics (Dopamine Antagonists)
Acute Treatment Guidelines
Emerging Acute Therapies
5-HT 1F Receptor Antagonists
CGRP Receptor Antagonists
References
Introduction
Impact Of Preventive Treatment
Principles Of Preventive Treatment
General Principles For Instituting Preventive Therapy
Guidelines For Stopping Preventive Therapy
Specific Migraine Preventive Agents
β-Adrenergic Blockers for the Prevention of Migraine
Antidepressant Medication for Migraine Prevention
Calcium Channel Antagonists for the Prevention of Migraine
Anti-epileptic Drugs for the Prevention of Migraine
Serotonin Antagonists
Methysergide
Cyproheptadine
Other Drugs For The Prevention Of Migraine
Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Antagonists
NSAIDs and Other Complementary Treatments for Episodic Migraine Prevention in Adults
Medicinal Herbs, Vitamins, And Other Interventions
Herbal Preparations, Vitamins, and Minerals
Aspirin and Other NSAIDS
New Preventive Medications
CGRP Antibody Antagonists[137]
Botulinum Toxin For Migraine
Formulations of Botulinum Toxin
Mechanism of Action of Botulinum Toxin in Headache
BoNT Treatment Techniques
Clinical Studies of BoNT's Efficacy in Headache Disorders
Adverse Events Associated with the Use of BoNT
Appendix 1: AAN Classification Of Evidence For The Rating Of A Therapeutic Study
Appendix 2: Classification Of Recommendations
References
Introduction
History Of CM/TM Classification
ICHD-1 (1988)
Silberstein-Lipton Criteria (1994, 1996)
ICHD-2 (2004)
ICHD-2R (2006)
ICHD-3 (Beta [P] Version)
Recommendations For Diagnostic Criteria For CM/TM
Differentiating CM from Other Chronic Daily Headaches
Medication Overuse Headache (MOH)
Definition and Classification of MOH
Clinical Features of MOH
Psychiatric Comorbidity Of CM
Other Comorbidities
Epidemiology Of CDH And CM
Risk Factors for CDH
Pathophysiology Of CM
Treatment
Overview
Acute Pharmacotherapy
Preventive Pharmacotherapy
Antidepressants
Anti-epileptic Drugs
Neurotoxins
Treatment with Limited Supporting Evidence
Other Medications
Opioid Maintenance
Non-pharmacological Treatment
Breaking the Headache Cycle
Strategies of Treatment
Prognosis
Why Treatment Fails
Prevention
References
Peripheral Nerve Stimulation
Occipital Nerve Stimulation
Sphenopalatine Ganglion Stimulation
Supraorbital Nerve Stimulation
Vagal Nerve Stimulation
Central Neurostimulation
Single-Pulse Transcranial Magnetic Stimulation
Repetitive Transcranial Magnetic Stimulation (rTMS)
Transcranial Direct Current Stimulation (tDCS)
References
Introduction
Menstruation And Migraine
Treatment Of Headaches Associated With The Menstrual Cycle
Overview
Acute Treatment
Preventive Treatment
Migraine Associated With Hormonal Contraceptive Use
Introduction
Transdermal Contraceptive Patch
Vaginal Rings
Injectable and Implantable Hormonal Contraception
Adverse Events
Contraceptive Use
References.